[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Pages 18624-18626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07839]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-0740]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to <a href="/cdn-cgi/l/email-protection#452a2827052621266b222a33"><span class="__cf_email__" data-cfemail="c8a7a5aa88abacabe6afa7be">[email protected]</span></a>. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

[[Page 18625]]

Proposed Project

    Medical Monitoring Project (MMP)--(OMB Control No. 0920-0740 
Expiration: 5/31/2015)--Revision--National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC), Division of 
HIV/AIDS Prevention (DHAP) requests a revision of the currently 
approved Information Collection Request: ``Medical Monitoring Project'' 
expiring May 31, 2015. This data collection addresses the need for 
national estimates of access to and utilization of HIV-related medical 
care and services, the quality of HIV-related ambulatory care, and HIV-
related behaviors and clinical outcomes.
    For the proposed project, the same data collection methods will be 
used as for the currently approved project. Data would be collected 
from a probability sample of HIV-diagnosed adults in the U.S. who 
consent to an interview and abstraction of their medical records. As 
for the currently approved project, de-identified information would 
also be extracted from HIV case surveillance records for a dataset, 
referred to as the minimum dataset, which is used to assess non-
response bias, for quality control, to improve the ability of MMP to 
monitor ongoing care and treatment of HIV-infected persons, and to make 
inferences from the MMP sample to HIV-diagnosed persons nationally. No 
other Federal agency collects such nationally representative 
population-based information from HIV-diagnosed adults. The data are 
expected to have significant implications for policy, program 
development, and resource allocation at the state/local and national 
levels.
    The changes proposed in this request update the data collection 
system to meet prevailing information needs and enhance the value of 
MMP data, while remaining within the scope of the currently approved 
project purpose. The result is a 16% reduction in burden, or a 
reduction of 1,397 total burden hours annually.
    <bullet> A change in sampling methods accounts for the net 
reduction in burden. Specifically, sampling from the existing HIV case 
surveillance database, the National HIV Surveillance System (NHSS, OMB 
Control No. 0920-0573, Exp. 2/29/2016) would replace the current health 
care-facility-based sampling. This change in sampling methods would 
broaden participation in MMP to all HIV-infected persons who have been 
diagnosed and reported to the NHSS, a population that is more 
representative of persons living with HIV than are persons receiving 
HIV medical care. Sampling from NHSS will allow MMP to address key 
information gaps related to increasing access to care, one of three 
strategic areas of national focus of the National HIV/AIDS Strategy. 
The change in project sampling methods reduces the amount of time 
health care facility staff will spend on project activities, 
substantially reducing burden hours and offsetting increases in burden 
from other changes, listed below. Restoration of the original sample of 
26 geographic primary sampling units is proposed in this request, for 
more complete coverage of the population of interest. Three project 
areas that initially participated in MMP--and were subsequently dropped 
in 2009 because funding was restricted--will be reinstated as primary 
sampling units if funding allows.
    <bullet> Increasing the sample size in three areas that were 
previously allocated comparatively small samples (Georgia, Illinois, 
and Pennsylvania) is expected to improve the ability to produce 
representative local estimates in these areas.
    <bullet> Health care facility staff may be asked to look up contact 
information for sampled persons with incomplete or incorrect contact 
information in NHSS; this was not necessary in prior MMP cycles because 
the patient samples were drawn from facility records.
    Finally, changes were made that did not affect the burden, listed 
below:
    <bullet> The interview instrument was revised to enable the 
collection of critical information from HIV-infected persons not 
receiving medical care and to improve question coherence, boost the 
efficiency of the data collection, and increase the relevance and value 
of the information. These changes were based on an evaluation of the 
currently approved MMP interview instrument involving stakeholders, as 
well as a pilot which evaluated new questions (Formative Research and 
Tool Development, OMB Control No. 0920-0840, expiration 2/29/2016). 
These revisions did not change the average time required to complete 
the interview.
    <bullet> Six data elements were removed from the medical record 
abstraction form and two data elements were added. Because the medical 
records are abstracted by MMP staff, these changes do not affect the 
burden of the project on the public.
    <bullet> Sampled persons may be interviewed wherever they currently 
reside, conditional on local law and policy, and in a manner specified 
by a written, project-specific agreement with the HIV surveillance unit 
at the person's local health department.
    <bullet> Videoconferencing was added as an optional mode of 
interview administration. Administering the interview via 
videoconferencing will provide more flexibility for participating in 
the interview and facilitate communication between respondent and 
interviewer, for example, by allowing interviewers to respond 
appropriately to a respondent's visual cues. Videoconferencing will 
also allow the interviewer to ensure that the respondent is using the 
correct response cards for interview questions. No audio/audiovisual 
recordings will be made of the interviews, including interviews 
administered by videoconferencing.
    This proposed data collection would supplement the National HIV 
Surveillance System (NHSS, OMB Control No. 0920-0573, Exp. 2/29/2016) 
in 26 selected state and local health departments, which collect 
information on persons diagnosed with, living with, and dying from HIV 
infection and AIDS.
    The participation of respondents is voluntary. There is no cost to 
the respondents other than their time. Through their participation, 
respondents will help to improve programs to prevent HIV infection as 
well as services for those who already have HIV. The total burden hours 
are 7,140.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average  hours
          Type of respondent                    Form name            Number of     responses per   per  response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Sampled, Eligible HIV-Infected Persons  Interview Questionnaire.           8,720               1           45/60
Facility office staff looking up        N/A.....................           2,180               1            2/60
 contact information.

[[Page 18626]]

 
Facility office staff approaching       N/A.....................           1,090               1            5/60
 sampled persons for enrollment.
Facility office staff pulling medical   N/A.....................           8,720               1            3/60
 records.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-07839 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>